drugset / Trial / NCT02371187

Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?

NCT02371187

Phase 2 Completed 37 enrolled Christopher Bell AstraZeneca · collab
RandomizedParallel-groupTriple-blindBasic science

Summary

Exercise is frequently prescribed as a favorable lifestyle intervention to prevent/reverse type 2 diabetes. It is also prescribed in addition to concurrent pharmacological treatment, such as metformin. Recent data (animal and human) suggest that metformin may attenuate the favorable benefits of exercise training. In light of the physiological mechanism of Dapagliflozin (sodium-glucose co-transporter 2 (SGLT2) inhibition), one might speculate that rather than inhibit, it will augment the favorable adaptations to exercise training.

Timeline

Start
2015-06
Primary completion
2018-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 10 mg Oral

Indications

No indication recorded.